Evaluation of the Quality of Prognosis Studies in Systematic Reviews
By J. Hayden, P. C.T, C. Bombardier. Annals of Internal Medicine, 2006
1,491 citations recorded by the source corpus.
Subfields: General Health Professions, Statistics and Probability
View Paper: https://www.semanticscholar.org/paper/fbd12a2270835f61902bc55411630138b67b295d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In General Health Professions
- Douglas G. Altman
- Gary S. Collins
- Johannes B Reitsma
- Karel G. M. Moons
- David Moher
- J. Tetzlaff
- Y. Vergouwe
- E. Coomes
In Statistics and Probability
- Douglas G. Altman
- Gary S. Collins
- Karel G. M. Moons
- Johannes B Reitsma
- David Moher
- J. Tetzlaff
- Y. Vergouwe
- J. Hayden
Citations in the corpus
- Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research (2013, neutral): “(recommendation 10) [61].”
- Assessing Bias in Studies of Prognostic Factors (2013, methodology): “During assessment of risk of bias, 6 important domains should be considered when evaluating validity and bias in studies of prognostic factors: study participation, study attrition, prognostic factor measurement, confounding measurement and account, outcome measurement, and analysis and reporting (1”
- Childhood obesity as a predictor of morbidity in adulthood: a systematic review and meta‐analysis (2016, methodology): “list, a tool designed for systematic reviews of prognostic studies (29,30).”
- Is depression associated with increased oxidative stress? A systematic review and meta-analysis. (2015, neutral): “For this urpose we adapted a tool by Hayden et al. (2006) (see ppendix B).”
- Sedentary Time and Its Association With Risk for Disease Incidence, Mortality, and Hospitalization in Adults (2015, methodology): “Each study was evaluated according to a standardized set of predefined criteria consisting of 15 items (Table 1) (15).”
- Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis. (2020, methodology): “Study risk of bias was assessed with the Quality In Prognosis Studies tool.(12) This prognostic risk of bias tool was”
- Interleukin‐6 in Covid‐19: A systematic review and meta‐analysis (2020, methodology): “Risk of bias was assessed via the QUIPS tool in cohort studies assessing inflammatory response in Covid-19.(26,27) Four studies were determined to be at high risk of bias,(33,35,37,38) five moderate,(29,31,32,34,36) and one low (Figure S1)(30); this was mostly driven by lack of control for confoundi”
- Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review (2015, methodology): “For the updated review, and being aware of more recent literature on assessing the quality of prognostic studies, we decided to keep S94 www.bjcancer.com | DOI:10.1038/bjc.2015.48 the original questions, as they were in line with the new Quality in Prognosis Studies tool (Hayden et al, 2006, 2013).”
- Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. (2009, neutral): “4 No — agshaw et al(30) Critically ill 5,693 1999-2002 Yes No Adults 65 Yes 63 agshaw et al(42) Critically ill 240 1999-2002 Yes No Adults 66 No 58 ahar et al(43) Cardiac surgery 168 1991-2001 No No Both 56 No 74 arratt et al(44) Cardiac surgery 65 1984-1996 No No Adults 69 No 92 enoit et al(45) Cri”